RMEBX
Price
$62.83
Change
+$0.38 (+0.61%)
Updated
Jun 2 closing price
Net Assets
114.65B
RYVVX
Price
$105.96
Change
+$0.28 (+0.26%)
Updated
Jun 2 closing price
Net Assets
9.63M
Interact to see
Advertisement

RMEBX vs RYVVX

Header iconRMEBX vs RYVVX Comparison
Open Charts RMEBX vs RYVVXBanner chart's image
RMEBX vs RYVVX Comparison Chart in %
View a ticker or compare two or three
VS
RMEBX vs. RYVVX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Hold and RYVVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 115B vs. RYVVX (9.63M). RMEBX pays higher dividends than RYVVX: RMEBX (1.04) vs RYVVX (0.23). RMEBX was incepted earlier than RYVVX: RMEBX (12 years) vs RYVVX (22 years). RYVVX (2.34) is less costly to investors than RMEBX (1.07). RYVVX is a more actively managed with annual turnover of: 2642.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than RYVVX: RMEBX (250) vs RYVVX (2500). RYVVX annual gain was more profitable for investors over the last year : 26.46 vs. RMEBX (9.98). RYVVX return over 5 years is better than : 40.72 vs. RMEBX (32.93).
RMEBXRYVVXRMEBX / RYVVX
Total Expense Ratio1.072.2947%
Annual Report Gross Expense Ratio1.072.3446%
Fund Existence12 years22 years-
Gain YTD5.8019.62760%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets115B9.63M1,194,433%
Annual Yield % from dividends1.040.23458%
Returns for 1 year9.9826.4638%
Returns for 3 years34.1455.3562%
Returns for 5 years32.9340.7281%
Returns for 10 years89.84102.3088%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX20.71N/A
N/A
Saratoga Health & Biotechnology A
PREPX29.10N/A
N/A
Principal Real Estate Securities R5
RGNCX59.51N/A
N/A
Victory Global Energy Transition C
PSGQX37.17N/A
N/A
PGIM Jennison Focused Growth R6
EPVIX14.41N/A
N/A
EuroPac International Value I